Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Jia Hu, Jingyi Huang, Wei Bian, Xiaoqing Zou, Yuanyuan Zhu, Weijia Huang, Yue Liang, Yi Zhao, Weiyan Zheng, Lixia Zhu, Xiu-Jin Ye, Yi Luo, Jimin Shi, Zhen Cai, He Huang, Shanshan Pei, Jie Sun

Blood (2025) 146 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2025-1508

Published: 2025

Journal Articles

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Yanmin Zhao, Yeqian Zhao, Shanshan Pei, Jimin Shi, Yi Luo, Jie Sun, Weiyan Zheng, Wenjun Wu, Yi Zhao, Lixia Zhu, Jian Yu, Lizhen Liu, Xiaoyu Lai, Huarui Fu, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2025-3404

Published: 2025

Journal Articles

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Lizhen Liu, Shipei Xiang, Xiaoyu Lai, Luxin Yang, Yibo Wu, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yishan Ye, Panpan Zhu, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 1061.

https://doi.org/10.1182/blood-2025-1061

Published: 2025

Journal Articles

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

Blood (2025) 146 (Supplement 1): 1059.

https://doi.org/10.1182/blood-2025-1059

Published: 2025

Journal Articles

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory chronic graft-versus-host disease

Yibo Wu, Lizhen Liu, Yi Chen, Xiaoyu Lai, Ying Lu, Luxin Yang, Lin Li, Lan Sun, Junjie Cao, Jimin Shi, Xiaolin Yuan, Panpan Zhu, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 7761.

https://doi.org/10.1182/blood-2025-7761

Published: 2025

Journal Articles

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2025-2523

Published: 2025

Journal Articles

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Ce Shi, Xiangjun Zeng, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, He Huang, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 584.

https://doi.org/10.1182/blood-2025-584

Published: 2025

Journal Articles

Low-dose chidamide maintenance therapy following allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia or lymphoma: A phase 2, open-label, multicenter, single-arm trial

Yi Yu, Weihao Chen, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Guifang Ouyang, He Huang, Lixia Sheng, Weijie Cao, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 169.

https://doi.org/10.1182/blood-2025-169

Published: 2025

Journal Articles

A scoring system for epstein-barr reativation after hematopoietic stem cell transplantation

Xinyu Wang, Yanmin Zhao, Jingsong He, Yi Luo, He Huang, Jimin Shi

Blood (2025) 146 (Supplement 1): 7811.

https://doi.org/10.1182/blood-2025-7811

Published: 2025

Journal Articles

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Fei Gao, Qi Wen, Jian-Ping Zhang, Yuanyuan Zhang, Na Xu, Yeqian Zhao, Jimin Shi, He Huang, Xiaofan Li, Yang Cao, Weijie Cao, Xiaodong Mo, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 2431.

https://doi.org/10.1182/blood-2025-2431

Published: 2025

Journal Articles

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Bingqian Jiang, Jian Yu, Yanmin Zhao, Yi Luo, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Congxiao Zhang, Yi Yu, Guanfang Zhang, He Huang, Jimin Shi

Blood (2025) 146 (Supplement 1): 2426.

https://doi.org/10.1182/blood-2025-2426

Published: 2025

Journal Articles

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Blood (2025) 146 (Supplement 1): 4270.

https://doi.org/10.1182/blood-2025-4270

Published: 2025

Journal Articles

Incidence and risk factors of Epstein–Barr virus reactivation and post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: A 985-patient retrospective cohort analysis

Fei Gao, Xinyu Wang, Yi Luo, Jian Yu, Huarui Fu, Xiaoyu Lai, Lizhen Liu, He Huang, Jimin Shi, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 4280.

https://doi.org/10.1182/blood-2025-4280

Published: 2025

Journal Articles

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Hengwei Wu, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Lizhen Liu, Xiaoyu Lai, Luxin Yang, Yishan Ye, Congxiao Zhang, Weijie Cao, Junjie Cao, Xiaojun Xu, Xiaoxia Hu, Ying Lu, He Huang, Yanmin Zhao

Blood (2024) 144 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2024-206823

Published: 2024

Journal Articles

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Blood (2024) 144 (Supplement 1): 7420.

https://doi.org/10.1182/blood-2024-209418

Published: 2024

Journal Articles

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2024) 144 (Supplement 1): 2171.

https://doi.org/10.1182/blood-2024-212040

Published: 2024

Journal Articles

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2024-200458

Published: 2024

Journal Articles

The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients

Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Weiyan Zheng, Jian Yu, Yanmin Zhao, Jie Sun, Xiujin Ye, Zhen Cai, He Huang, Shanshan Pei, Yi Luo

Blood (2024) 144 (Supplement 1): 843.

https://doi.org/10.1182/blood-2024-209592

Published: 2024

Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Blood (2024) 144 (Supplement 1): 97.

https://doi.org/10.1182/blood-2024-204703

Published: 2024

Journal Articles

Glycolysis-Driven IFN-γ Expression in T-Cell Via Histone Lactylation Promotes Acute Graft-Versus-Host Disease

Hengwei Wu, Xin Jin, Fei Gao, Jimin Shi, Yi Luo, He Huang, Yanmin Zhao

Blood (2023) 142 (Supplement 1): 6802.

https://doi.org/10.1182/blood-2023-182560

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory chronic graft-versus-host disease

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Low-dose chidamide maintenance therapy following allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia or lymphoma: A phase 2, open-label, multicenter, single-arm trial

A scoring system for epstein-barr reativation after hematopoietic stem cell transplantation

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Incidence and risk factors of Epstein–Barr virus reactivation and post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: A 985-patient retrospective cohort analysis

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Glycolysis-Driven IFN-γ Expression in T-Cell Via Histone Lactylation Promotes Acute Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only